Lung Cancer Surgery Market SWOT Analysis by 2031
Lung cancer surgery is used to perform to remove tumor along with some surrounding lung tissues. The surgery is depend on the type, location and stage of the lung cancer and other medical conditions. The surgery includes early stage non-small cell lung cancers and carcinoid tumors. There are four types of lung surgery namely, pneumonectomy, lobectomy, segmentectomy or wedge resection and sleeve resection.
MARKET DYNAMICS
The lung cancer surgery market is anticipated to grow in the forecast, owing to growing ageing population, increasing prevalence of lung cancer and rising awareness about advanced treatment methods. In addition, rising cases of lung cancer is expected to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Global Lung Cancer Surgery Market Analysis to 2031" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of lung cancer surgery market with detailed market segmentation by product, procedure and geography. The global lung cancer surgery market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading lung cancer surgery market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global lung cancer surgery market is segmented on the basis product and procedure. Based on product, the market is segmented as, surgical instruments and monitoring and visualizing systems. On the basis of procedure, the market is bifurcated into thoracotomy and minimally invasive surgeries.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global lung cancer surgery market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The lung cancer surgery market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting lung cancer surgery market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the lung cancer surgery market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global lung cancer surgery market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The lung cancer surgery market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting lung cancer surgery market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the lung cancer surgery market in these regions.
MARKET PLAYERS
The reports cover key developments in the lung cancer surgery market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from lung cancer surgery market are anticipated to lucrative growth opportunities in the future with the rising demand for lung cancer surgery market in the global market. Below mentioned is the list of few companies engaged in the lung cancer surgery market.
The report also includes the profiles of key lung cancer surgery market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- KARL STORZ SE & Co. KG
- Olympus Corporation
- Ethicon Us, LLC (Johnson & Johnson)
- Accuray Incorporated
- Teleflex Incorporated
- AngioDynamics
- Scanlan International
- Intuitive Surgical
- TROKAMED GmbH
- Ackermann Instrumente GmbH
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Lung Cancer Surgery Market - By Product
1.3.2 Lung Cancer Surgery Market - By Procedure
1.3.3 Lung Cancer Surgery Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. LUNG CANCER SURGERY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. LUNG CANCER SURGERY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. LUNG CANCER SURGERY MARKET - GLOBAL MARKET ANALYSIS
6.1. LUNG CANCER SURGERY - GLOBAL MARKET OVERVIEW
6.2. LUNG CANCER SURGERY - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. LUNG CANCER SURGERY MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. SURGICAL INSTRUMENTS
7.3.1. Overview
7.3.2. Surgical Instruments Market Forecast and Analysis
7.4. MONITORING AND VISUALIZING SYSTEMS
7.4.1. Overview
7.4.2. Monitoring and Visualizing Systems Market Forecast and Analysis
8. LUNG CANCER SURGERY MARKET - REVENUE AND FORECASTS TO 2028 - PROCEDURE
8.1. OVERVIEW
8.2. PROCEDURE MARKET FORECASTS AND ANALYSIS
8.3. THORACOTOMY
8.3.1. Overview
8.3.2. Thoracotomy Market Forecast and Analysis
8.4. MINIMALLY INVASIVE SURGERIES
8.4.1. Overview
8.4.2. Minimally Invasive Surgeries Market Forecast and Analysis
9. LUNG CANCER SURGERY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Lung Cancer Surgery Market Overview
9.1.2 North America Lung Cancer Surgery Market Forecasts and Analysis
9.1.3 North America Lung Cancer Surgery Market Forecasts and Analysis - By Product
9.1.4 North America Lung Cancer Surgery Market Forecasts and Analysis - By Procedure
9.1.5 North America Lung Cancer Surgery Market Forecasts and Analysis - By Countries
9.1.5.1 United States Lung Cancer Surgery Market
9.1.5.1.1 United States Lung Cancer Surgery Market by Product
9.1.5.1.2 United States Lung Cancer Surgery Market by Procedure
9.1.5.2 Canada Lung Cancer Surgery Market
9.1.5.2.1 Canada Lung Cancer Surgery Market by Product
9.1.5.2.2 Canada Lung Cancer Surgery Market by Procedure
9.1.5.3 Mexico Lung Cancer Surgery Market
9.1.5.3.1 Mexico Lung Cancer Surgery Market by Product
9.1.5.3.2 Mexico Lung Cancer Surgery Market by Procedure
9.2. EUROPE
9.2.1 Europe Lung Cancer Surgery Market Overview
9.2.2 Europe Lung Cancer Surgery Market Forecasts and Analysis
9.2.3 Europe Lung Cancer Surgery Market Forecasts and Analysis - By Product
9.2.4 Europe Lung Cancer Surgery Market Forecasts and Analysis - By Procedure
9.2.5 Europe Lung Cancer Surgery Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Lung Cancer Surgery Market
9.2.5.1.1 Germany Lung Cancer Surgery Market by Product
9.2.5.1.2 Germany Lung Cancer Surgery Market by Procedure
9.2.5.2 France Lung Cancer Surgery Market
9.2.5.2.1 France Lung Cancer Surgery Market by Product
9.2.5.2.2 France Lung Cancer Surgery Market by Procedure
9.2.5.3 Italy Lung Cancer Surgery Market
9.2.5.3.1 Italy Lung Cancer Surgery Market by Product
9.2.5.3.2 Italy Lung Cancer Surgery Market by Procedure
9.2.5.4 Spain Lung Cancer Surgery Market
9.2.5.4.1 Spain Lung Cancer Surgery Market by Product
9.2.5.4.2 Spain Lung Cancer Surgery Market by Procedure
9.2.5.5 United Kingdom Lung Cancer Surgery Market
9.2.5.5.1 United Kingdom Lung Cancer Surgery Market by Product
9.2.5.5.2 United Kingdom Lung Cancer Surgery Market by Procedure
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Lung Cancer Surgery Market Overview
9.3.2 Asia-Pacific Lung Cancer Surgery Market Forecasts and Analysis
9.3.3 Asia-Pacific Lung Cancer Surgery Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Lung Cancer Surgery Market Forecasts and Analysis - By Procedure
9.3.5 Asia-Pacific Lung Cancer Surgery Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Lung Cancer Surgery Market
9.3.5.1.1 Australia Lung Cancer Surgery Market by Product
9.3.5.1.2 Australia Lung Cancer Surgery Market by Procedure
9.3.5.2 China Lung Cancer Surgery Market
9.3.5.2.1 China Lung Cancer Surgery Market by Product
9.3.5.2.2 China Lung Cancer Surgery Market by Procedure
9.3.5.3 India Lung Cancer Surgery Market
9.3.5.3.1 India Lung Cancer Surgery Market by Product
9.3.5.3.2 India Lung Cancer Surgery Market by Procedure
9.3.5.4 Japan Lung Cancer Surgery Market
9.3.5.4.1 Japan Lung Cancer Surgery Market by Product
9.3.5.4.2 Japan Lung Cancer Surgery Market by Procedure
9.3.5.5 South Korea Lung Cancer Surgery Market
9.3.5.5.1 South Korea Lung Cancer Surgery Market by Product
9.3.5.5.2 South Korea Lung Cancer Surgery Market by Procedure
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Lung Cancer Surgery Market Overview
9.4.2 Middle East and Africa Lung Cancer Surgery Market Forecasts and Analysis
9.4.3 Middle East and Africa Lung Cancer Surgery Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Lung Cancer Surgery Market Forecasts and Analysis - By Procedure
9.4.5 Middle East and Africa Lung Cancer Surgery Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Lung Cancer Surgery Market
9.4.5.1.1 South Africa Lung Cancer Surgery Market by Product
9.4.5.1.2 South Africa Lung Cancer Surgery Market by Procedure
9.4.5.2 Saudi Arabia Lung Cancer Surgery Market
9.4.5.2.1 Saudi Arabia Lung Cancer Surgery Market by Product
9.4.5.2.2 Saudi Arabia Lung Cancer Surgery Market by Procedure
9.4.5.3 U.A.E Lung Cancer Surgery Market
9.4.5.3.1 U.A.E Lung Cancer Surgery Market by Product
9.4.5.3.2 U.A.E Lung Cancer Surgery Market by Procedure
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Lung Cancer Surgery Market Overview
9.5.2 South and Central America Lung Cancer Surgery Market Forecasts and Analysis
9.5.3 South and Central America Lung Cancer Surgery Market Forecasts and Analysis - By Product
9.5.4 South and Central America Lung Cancer Surgery Market Forecasts and Analysis - By Procedure
9.5.5 South and Central America Lung Cancer Surgery Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Lung Cancer Surgery Market
9.5.5.1.1 Brazil Lung Cancer Surgery Market by Product
9.5.5.1.2 Brazil Lung Cancer Surgery Market by Procedure
9.5.5.2 Argentina Lung Cancer Surgery Market
9.5.5.2.1 Argentina Lung Cancer Surgery Market by Product
9.5.5.2.2 Argentina Lung Cancer Surgery Market by Procedure
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. LUNG CANCER SURGERY MARKET, KEY COMPANY PROFILES
11.1. KARL STORZ SE AND CO. KG
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. OLYMPUS CORPORATION
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ETHICON US, LLC (JOHNSON AND JOHNSON)
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ACCURAY INCORPORATED
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. TELEFLEX INCORPORATED
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ANGIODYNAMICS
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SCANLAN INTERNATIONAL
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. INTUITIVE SURGICAL
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. TROKAMED GMBH
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. ACKERMANN INSTRUMENTE GMBH
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. KARL STORZ SE & Co. KG2. Olympus Corporation3. Ethicon Us, LLC (Johnson & Johnson)4. Accuray Incorporated5. Teleflex Incorporated6. AngioDynamics7. Scanlan International8. Intuitive Surgical9. TROKAMED GmbH10. Ackermann Instrumente GmbH
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.